Objective To explore the outcomes associated with fetal hepatobiliary cysts. (47.9% (95% CI, 
INTRODUCTION
Advances in prenatal imaging techniques have led to an increased detection rate of fetal abdominal cysts 1, 2 . These cysts originate from various structures within the fetal abdomen and pelvis, but most commonly are renal, bowel, mesenteric, ovarian, pancreatic, splenic, hepatic or biliary in origin.
Hepatobiliary cysts encompass a wide spectrum of conditions with different etiology, prevalence and clinical manifestations 1 . On prenatal ultrasound, hepatobiliary cysts appear as anechoic or hypoechoic round structures within the liver parenchyma, which may or may not communicate with the biliary tree. The importance of an accurate prenatal diagnosis of these anomalies lies in the fact that, while hepatic cysts are commonly considered a benign entity with a low likelihood of postnatal symptoms and need for surgery, biliary cysts may present with symptoms related to cholestasis in the neonatal period, thus requiring prompt surgical intervention. Furthermore, biliary cysts may be misdiagnosed as biliary atresia, a congenital anomaly characterized by agenesis of the bile ducts that may lead to portal hypertension, cirrhosis and eventually liver failure if left untreated 1, 3 . Accurate prenatal diagnosis of hepatic and biliary cysts may be challenging, especially because other abdominal anomalies, such as obstructive lesions of the gastrointestinal tract, have a similar ultrasound appearance 1, 2 . Antenatal counseling when a cystic structure is detected in the fetal liver is difficult; evidence is sparse and mainly derived from small series. This is important, as parental counseling based on single small studies that are subject to publication bias may be inadequate. Several adverse outcomes, such as abdominal pain, cyst rupture and symptoms related to bile obstruction, such as cholestasis, cholangitis and liver fibrosis, have been reported to be associated with hepatobiliary cysts. However, these data come from postnatal studies including mainly symptomatic children. Furthermore, the actual occurrence of congenital anomalies of the biliary tree, such as biliary atresia, in which a cystic structure is detected in the fetal liver, is still unknown. Finally, the diagnostic performance of prenatal ultrasound in correctly identifying these anomalies has not yet been completely elucidated. The aim of this systematic review was to explore the outcomes of fetal hepatobiliary cysts.
METHODS

Protocol, eligibility criteria, information sources and search
This review was performed according to an a-priori designed protocol recommended for systematic reviews and meta-analyses and following the PRISMA guidelines [4] [5] [6] . MEDLINE and EMBASE databases were searched electronically on 25 October 2015 and the search was updated on 11 February 2016, utilizing combinations of the relevant medical subject heading (MeSH) terms, keywords and word variants for 'hepatic', 'choledochal', 'biliary', 'cyst' and 'outcome' (Table S1 ). The search and selection criteria were restricted to the English language. Reference lists of relevant articles and reviews were searched manually for additional reports.
The study was registered with the PROSPERO database (registration number: CRD42016039559).
Study selection, data collection and data items
Two authors (M.L., D.B.) reviewed all abstracts independently. Agreement regarding potential relevance was reached by consensus; full-text copies of papers deemed to be relevant were obtained and the same two reviewers independently extracted relevant data regarding study characteristics and pregnancy outcomes. Inconsistencies were discussed by the reviewers and consensus reached between them or by discussion with a third author (F.D.). If more than one study was published for the same cohort with identical endpoints, the report containing the most comprehensive information on the population was included to avoid overlapping populations.
Only studies reporting prenatal diagnoses of hepatic and/or biliary cysts were considered suitable for inclusion in the systematic review; studies including only postnatally diagnosed cases or studies from which prenatally diagnosed cases could not be extracted were excluded. Autopsy-based studies were excluded on the basis that fetuses that underwent termination of pregnancy are more likely to show associated anomalies. Studies published before 2000 were excluded, as we considered that advances in prenatal imaging techniques and improvements in the diagnosis and definition of fetal anomalies made them less relevant. Studies including exclusively cases diagnosed in the first trimester without subsequent follow-up and/or clear postnatal diagnosis were not considered suitable for inclusion in the review. Finally, studies not providing a clear classification of the anomaly were not considered suitable for inclusion in the review.
Only full-text articles were considered eligible for inclusion; case reports, conference abstracts and case series with fewer than three cases of hepatobiliary cysts, irrespective of whether the anomalies were isolated or not, were also excluded in order to avoid publication bias.
Quality assessment of included studies was performed using the Newcastle-Ottawa Scale (NOS); according to the NOS, each study is judged on three broad perspectives: selection of study groups, comparability of groups and ascertainment of the outcome of interest. Assessment of the selection of a study includes evaluation of the representativeness of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and demonstration that the outcome of interest was not present at the start of the study. Assessment of the comparability of the study includes evaluation of the comparability of cohorts on the basis of the design or analysis. Finally, ascertainment of the outcome of interest includes evaluation of the type of assessment of the outcome of interest and length and adequacy of follow-up 7 . According to NOS, a study can be awarded a maximum of one star for each numbered item within the selection and outcome categories. A maximum of two stars can be given for comparability.
Risk of bias, summary measures and synthesis of results
The incidence of the following outcomes was analyzed in fetuses with hepatobiliary cysts: resolution/reduction in cyst size, increase in cyst size, associated congenital anomalies of the biliary tract, associated congenital anomalies of the liver, abnormal postnatal liver function test, overall occurrence of symptoms due to the presence of the cyst, symptoms related to bile obstruction, all other symptoms related to the presence of the cyst, need for surgery and postsurgical complications.
A hepatic cyst was defined as a cyst located within the liver parenchyma and a biliary cyst was defined as a congenital dilatation of single or multiple branches of the biliary tract or a cyst located in close proximity to the gallbladder and having direct connection with the biliary tract.
All outcomes were assessed in the overall population of fetuses with hepatic and/or biliary cysts; subgroup analysis was performed for hepatic and biliary cysts separately, because differential prenatal diagnosis between hepatic and biliary cysts is not always feasible.
Statistical analysis
We used meta-analyses of proportions to combine data 8 . Funnel plots displaying the outcome rate from individual studies vs their precision (1/standard error) were constructed with an exploratory aim. Tests for funnel-plot asymmetry were not used when the total number of publications included for each outcome was below 10. In such cases, the power of the tests is too low to distinguish chance from real asymmetry 9, 10 . Between-study heterogeneity was explored using the I 2 statistic, which represents the percentage of between-study variation that is due to heterogeneity rather than chance. A value of 0% indicates no observed heterogeneity, while I 2 values ≥ 50% indicate a substantial level of heterogeneity. A random-effects model was used for all meta-analyses. Potential publication bias was formally assessed through Egger's regression asymmetry test.
We also evaluated separately the association between hepatobiliary cyst size, comparing cysts ≥ 20 mm, ≥ 30 mm and ≥ 40 mm with those < 20 mm, < 30 mm and < 40 mm, respectively, and the two clinical outcomes, resolution of the cyst and presence of symptoms.
We included observational cohort studies in which: (1) many comparisons reported zero events in one group; (2) several comparisons reported zero events in both groups; and (3) exposed and unexposed group sizes were frequently severely unbalanced. In such cases, many of the most commonly used meta-analytical methods, including those using risk difference (which could be used to handle total zero event studies), can produce biased estimates when events are rare 11, 12 . When many studies are also substantially imbalanced, the best performing methods are the Mantel-Haenszel odds ratio without zero-cell continuity corrections, logistic regression and an exact method 13, 14 . Mantel-Haenszel odds ratios cannot be computed in studies reporting zero events in both groups, the exclusion of which may however cause a relevant loss of information and the potential inflation of the magnitude of the pooled exposure effect 11 . Therefore, to keep all studies in the analyses, we aimed to perform all meta-analyses using individual data random-effect logistic regression, with single study as the cluster unit 13, 14 . The pooled datasets with individual data were reconstructed using published 2 × 2 tables. When one of the overall pooled arms showed no events, we aimed to use exact logistic regression. 
RESULTS
Study selection and characteristics
The electronic search identified 1498 articles, of which 101 were assessed for their eligibility for inclusion. Seventy-nine articles were excluded (Table S2 ) and 22 studies including 252 fetuses with hepatic (n = 49) and biliary (n = 203) cysts were included in the systematic review (Table 1 and Figure 1 ) . Quality assessment of the included studies was performed using NOS for cohort studies ( Table 2 ). Most of the included studies showed an overall good rate with regard to the selection and comparability of the study groups and for ascertainment of the outcome of interest. The main weaknesses of these studies were their retrospective design, small sample size and lack of detailed ultrasound characteristics, different times at follow-up and wide heterogeneity in postnatal management.
Synthesis of results
All cysts
When considering all hepatobiliary cysts together, the rate of resolution or reduction in cyst size either prenatally or postnatally was 21.6% (95% CI, 8.4-38.8%), while in 27.2% (95% CI, 14.2-42.6%) of cases, the cyst showed an increase in diameter at prenatal or postnatal imaging. Additional congenital anomalies in the biliary tract, such as biliary atresia or agenesis, and in the liver parenchyma occurred in 15.5% (95% CI, 7.0-26.5%) and 14.9% (95% CI, 4.8-29.2%) of cases, respectively (Table 3 and Figure S1 ).
At birth, 60.1% (95% CI, 37.4-80.6%) of cases had an abnormal liver function test. Clinical symptoms were present in 48.2% (95% CI, 31.9-64.7%) of children with a confirmed prenatal diagnosis of hepatobiliary cyst, and in 39.0% (95% CI, 21.4-58.3%) they were related exclusively to bile obstruction. After birth, 73.8% (95% CI, 55.7-88.5%) of cases had surgery, and postsurgical complications occurred in 12.3% (95% CI, 4.3-23.7%) of the operated cases (Table 3 and Figure S1 ).
Hepatic cysts
Nine studies including 49 fetuses with a prenatal diagnosis of hepatic cyst that was confirmed at birth were included in the review. The rate of resolution or reduction in cyst size, either prenatally or postnatally, was 59.3% (95% CI, 30.9-84.7%), while an increase in cyst size occurred in 8.7% (95% CI, 1.1-22.4%) of cases. No case of hepatic cyst had associated malformations of the biliary tract at birth, while other liver anomalies occurred in 6.7% (95% CI, 1.6-14.7%) of cases (Table 3 and Figure  S2 ). Clinical symptoms were present in 14.8% (95% CI, Only first author given for each study. *Data are given as mean, mean ± SD or mean (range) unless stated otherwise. GA, gestational age; m, months; NS, not stated; PNI, postnatal imaging; Prosp, prospective; Retro, retrospective; y, years.
6.3-26.1%) of cases and, in 5.4% (95% CI, 0.9-13.6%), they were related to the presence of bile obstruction due to compression of the cyst on the biliary tract. No case of hepatic cyst had an abnormal liver function test at birth. After birth, 18.3% (95% CI, 6.7-33.9%) of cases with a prenatal diagnosis of hepatic cyst confirmed at birth underwent surgery and none experienced postsurgical complications (Table 3 and Figure S2 ).
Biliary cysts
Twenty studies including 203 fetuses with a prenatal diagnosis of biliary cyst that was confirmed at birth were included in the review. (Table 3 and Figure S3 ).
Risk estimation
Data extraction for risk assessment was performed for resolution/regression and increase in cyst size and presence of symptoms, according to different cut-offs of cyst size (≥ 20, ≥ 30 or ≥ 40 mm vs < 20, < 30 and < 40 mm). Unfortunately, the majority of the comparisons reported the presence or absence of the events in both groups. In this scenario, comprehensive data synthesis was not possible.
DISCUSSION
The findings of this systematic review show that about 60% of fetal hepatic cysts regress either before or after birth, while an increase in cyst size may occur in a small proportion of cases. The risk of associated anomalies of the biliary tract or liver is negligible and a large majority of children with congenital hepatic cysts have a very low likelihood of developing abnormal liver function or clinical symptoms. Conversely, biliary cysts showed an increase in size either before or after birth in about one-third of cases, while only a small proportion regressed. Congenital anomalies of the biliary tract or liver occurred in about 20% and 17% of cases, respectively. Almost 60% of children with biliary cysts diagnosed prenatally showed impairment in liver function and clinical symptoms, mainly due to bile obstruction.
Strengths and limitations of the study
The small number of cases in most of the included studies, their retrospective non-randomized design, different periods of follow-up, dissimilarity of the populations (owing to various inclusion criteria), the lack of fixed criteria for when to treat and postnatal confirmation represent the major limitations of this systematic review. Assessment of potential publication bias was also problematic, both because of the outcome nature (rates, with the left-side limited to a value of zero), which limits the reliability of funnel plots, and because of the scarce number of individual studies, which strongly limits the reliability of formal tests. Most of the observed outcomes were reported by only a limited proportion of the included studies. Furthermore, 15 Catania (2016) 16 Marchitelli (2015) 17 Tang (2015) 18 Tanaka (2015) 19 Thakkar (2014) 20 Weng (2016) 21 Celebi (2014) 22 Cong (2015) 23 Cherqaoui (2012) 24 Diao (2012) 25 Holschbach (2012) 26 Ozyuncu (2010) 27 Foo (2009) 28 Bronstein (2009) 29 Charlesworth (2007) 30 Saito (2006) 31 Hinds (2004) 32 Okada (2004) 33 Casaccia (2002) 34 Hasegawa (2002) 35 MacKenzie (2001) 36 A maximum of one star can be given for each numbered item within selection and outcome categories. A maximum of two stars can be given for comparability.
we could not stratify the analysis according to different cut-offs for cyst size in view of the fact that the majority of these were reported by only a few studies, thus considerably limiting interpretation of the results. Biliary cysts are usually classified according to the site of dilatation of the biliary tract. In the current review, it was not possible to stratify the outcome of these anomalies according to the site of dilatation in view of the fact that this information was not reported by the large majority of the included studies. Ascertainment of some of the outcomes observed, such as surgery, was also considerably biased by the varied postnatal management strategies adopted in different centers. This might, in turn, have led to overestimation of some of the values reported in the present review. Despite these limitations, this systematic review represents the best published analysis of the investigated outcomes in fetuses diagnosed with hepatobiliary cysts.
Implications for clinical practice
Advances in prenatal imaging techniques have led to an increase in the diagnosis of fetal abdominal cysts. Hepatobiliary cysts are rare congenital anomalies involving either the hepatic parenchyma or the biliary tract, and are usually classified according to their location. Although a direct comparison between hepatic and biliary cysts could not be performed owing to the study design and very small number of cases in the included studies, biliary cysts showed a high likelihood for progression, abnormal liver function and clinical symptoms due to bile obstruction. Congenital hepatic cysts showed a low likelihood for progression, and resolution or a decrease in cyst size was common. Furthermore, the occurrence of abnormal liver function and clinical symptoms was low. Cyst size and appearance on ultrasound have been recognized as the main determinants of the perinatal outcome of ovarian cysts; large cysts measuring ≥ 4 mm and complex cysts have been shown to carry an increased risk for torsion, hemorrhage and the need for oophorectomy 37 . In this systematic review it was not possible to stratify the results according to cyst size and appearance. However, it might be reasonable to perform a closer follow-up of large hepatic cysts, in order to detect promptly signs of bowel obstruction, such as dilated bowel loops and polyhydramnios.
The findings of this systematic review showed that biliary atresia was present in 22% of fetuses diagnosed as having biliary cysts on prenatal ultrasound. Biliary cystic atresia is a congenital anomaly which, if left untreated, is characterized by a worse outcome -such as portal hypertension, cirrhosis and liver failure -than that of simple biliary cysts. Differential diagnosis between simple biliary cysts and cystic biliary atresia on prenatal ultrasound is challenging and has been reported only occasionally. Several ultrasound signs, such as abnormal shape of the gallbladder and change in cyst size and patterns and timing of their occurrence, have been proposed to be associated with an increased risk of biliary atresia 38 . Furthermore, an increased risk for biliary atresia has been reported in fetuses in which the gallbladder could not be visualized, irrespective of the presence of a cystic structure within the hepatic hilum 39 . However, these figures come from small retrospective studies, including mainly highly selected cases, and biliary cystic atresia usually has the same ultrasound appearance as does a simple biliary cyst. In the present review, we included cases of biliary atresia that presented as a cystic structure within the liver on prenatal ultrasound. Therefore, it is entirely plausible that some of the figures reported for biliary cysts, such as abnormal liver tests and presence of clinical symptoms, might have been overestimated by including several cases of biliary cystic atresia.
Differential prenatal diagnosis between hepatic and biliary cysts is challenging. Biliary cysts are located in close proximity to the porta hepatis and communicate with the biliary tract. Furthermore, they are usually associated with intra-and/or extrahepatic dilatation of the biliary ducts. On the other hand, simple hepatic cysts present as anechoic lesions within the hepatic parenchyma and usually do not communicate with the biliary tree 2,3 . However, this communication is not always visible on the ultrasound scan, especially when the cyst is large, and biliary dilatation may not always be present prenatally. In view of these limitations, antenatal counseling of women presenting with a fetus with a cystic structure within the liver should mention that ultrasound is not always able to differentiate between hepatic and biliary cysts and that prompt postnatal assessment is needed in order to confirm the prenatal diagnosis.
Fetal magnetic resonance imaging (fMRI) has been suggested as a means of adding supplementary information to ultrasound in cases of abdominal anomalies 40 . In view of its excellent anatomical localization and contrast resolution, fMRI might theoretically help in better defining the relationship between the cyst and the ductal tree, thus improving the diagnostic accuracy of ultrasound. Further studies on the role of fMRI in the diagnosis and risk stratification of fetuses with an ultrasound diagnosis of hepatobiliary cyst are needed in order to ascertain its role in the antenatal management of these anomalies.
The postnatal course of hepatobiliary cysts is related to the type of cyst and can vary from an entirely asymptomatic lesion to a life-threatening condition. In the current review, congenital hepatic cysts had a negligible risk for abnormal liver function and postnatal symptoms, results that are in line with postnatal studies claiming relatively good outcomes for these anomalies. Isolated hepatic cysts are usually followed up non-invasively, although large cysts or those in close proximity to the hepatic hilum are treated in order to reduce the risk of cyst enlargement, infection, spontaneous perforation, internal bleeding, malignant degeneration or compression of the biliary tract [41] [42] [43] . Clinical symptoms occurred in 55% of fetal biliary cysts and were related to bile obstruction in the large majority of cases. Furthermore, about half the affected children showed impaired liver function after birth. This highlights the importance of immediate postnatal evaluation by a pediatric surgeon and the need for immediate imaging evaluation to confirm the presence, type and exact location of the cyst in order to properly tailor postnatal management. Total excision of the cyst with Roux-en-Y hepaticoenterostomy, either by laparoscopy or laparotomy, is the treatment of choice for simple biliary cysts in children 32 . The outcome after surgical resection has usually been reported to be excellent, although possible long-term complications such as biliary leakage or a need for re-operation can occur, thus emphasizing the need for serial follow-up after surgery.
In conclusion, fetal hepatic cysts are benign conditions with a low likelihood of associated anomalies of the hepatobiliary tract, abnormal liver function and clinical symptoms. However, congenital biliary cysts are associated with a high rate of progression, abnormal liver function and clinical symptoms. Accurate differential diagnosis between hepatic and biliary cysts is fundamental because a significant proportion of cysts labeled as choledochal prenatally are diagnosed as biliary atresia postnatally, thus requiring strict follow-up and prompt intervention. Further studies are needed in order to develop objective ultrasound signs for correctly stratifying the outcome of fetuses with a prenatal diagnosis of hepatobiliary cyst and to identify accurately those that will benefit from strict postnatal follow-up, such as those with biliary atresia.
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